

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 9.13186100 |
| 2 | regulation of sequestering of triglyceride (GO:0010889) | 8.00015689 |
| 3 | triglyceride catabolic process (GO:0019433) | 7.36630781 |
| 4 | acylglycerol catabolic process (GO:0046464) | 6.61951553 |
| 5 | neutral lipid catabolic process (GO:0046461) | 6.61951553 |
| 6 | white fat cell differentiation (GO:0050872) | 6.59523701 |
| 7 | brown fat cell differentiation (GO:0050873) | 6.55141019 |
| 8 | fatty acid transmembrane transport (GO:1902001) | 6.32609880 |
| 9 | valine metabolic process (GO:0006573) | 6.25055690 |
| 10 | biotin metabolic process (GO:0006768) | 6.17796596 |
| 11 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.98828765 |
| 12 | lipid particle organization (GO:0034389) | 5.89557818 |
| 13 | carnitine shuttle (GO:0006853) | 5.87101754 |
| 14 | positive regulation of fatty acid oxidation (GO:0046321) | 5.75188911 |
| 15 | response to dietary excess (GO:0002021) | 5.31094875 |
| 16 | regulation of cholesterol storage (GO:0010885) | 5.19024024 |
| 17 | transcytosis (GO:0045056) | 5.18310799 |
| 18 | triglyceride biosynthetic process (GO:0019432) | 5.13207835 |
| 19 | fatty acid beta-oxidation (GO:0006635) | 5.11111499 |
| 20 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 4.95840434 |
| 21 | acylglycerol biosynthetic process (GO:0046463) | 4.94091141 |
| 22 | neutral lipid biosynthetic process (GO:0046460) | 4.94091141 |
| 23 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.92970095 |
| 24 | glycerolipid catabolic process (GO:0046503) | 4.89159508 |
| 25 | carnitine transmembrane transport (GO:1902603) | 4.70310327 |
| 26 | lipid storage (GO:0019915) | 4.67667808 |
| 27 | regulation of fatty acid oxidation (GO:0046320) | 4.58396676 |
| 28 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.52627510 |
| 29 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 4.52340786 |
| 30 | polyol transport (GO:0015791) | 4.49044440 |
| 31 | fatty acid homeostasis (GO:0055089) | 4.48058745 |
| 32 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 4.46951929 |
| 33 | fatty acid oxidation (GO:0019395) | 4.44357176 |
| 34 | ovulation from ovarian follicle (GO:0001542) | 4.36911181 |
| 35 | lipid oxidation (GO:0034440) | 4.35803298 |
| 36 | fatty acid catabolic process (GO:0009062) | 4.35017510 |
| 37 | amino-acid betaine transport (GO:0015838) | 4.31153678 |
| 38 | carnitine transport (GO:0015879) | 4.31153678 |
| 39 | branched-chain amino acid metabolic process (GO:0009081) | 4.25120594 |
| 40 | triglyceride metabolic process (GO:0006641) | 4.17155326 |
| 41 | acyl-CoA biosynthetic process (GO:0071616) | 4.13628516 |
| 42 | thioester biosynthetic process (GO:0035384) | 4.13628516 |
| 43 | coenzyme A biosynthetic process (GO:0015937) | 4.09402343 |
| 44 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.05895986 |
| 45 | branched-chain amino acid catabolic process (GO:0009083) | 4.05091727 |
| 46 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.04542458 |
| 47 | protein heterotrimerization (GO:0070208) | 4.03798914 |
| 48 | ethanol oxidation (GO:0006069) | 4.03273400 |
| 49 | oxaloacetate metabolic process (GO:0006107) | 4.00277583 |
| 50 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.99920445 |
| 51 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.99170432 |
| 52 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.97671308 |
| 53 | acylglycerol metabolic process (GO:0006639) | 3.95519830 |
| 54 | acetyl-CoA metabolic process (GO:0006084) | 3.92717430 |
| 55 | positive regulation of lipid catabolic process (GO:0050996) | 3.92502310 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 3.91692853 |
| 57 | neutral lipid metabolic process (GO:0006638) | 3.89856715 |
| 58 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.89130816 |
| 59 | positive regulation of glucose import (GO:0046326) | 3.82872388 |
| 60 | response to phenylpropanoid (GO:0080184) | 3.80108943 |
| 61 | negative regulation of protein autophosphorylation (GO:0031953) | 3.76058278 |
| 62 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.76037748 |
| 63 | alpha-linolenic acid metabolic process (GO:0036109) | 3.74348929 |
| 64 | regulation of gonadotropin secretion (GO:0032276) | 3.73990850 |
| 65 | positive regulation of lipid storage (GO:0010884) | 3.73287455 |
| 66 | tricarboxylic acid metabolic process (GO:0072350) | 3.72440418 |
| 67 | cellular response to epinephrine stimulus (GO:0071872) | 3.71291060 |
| 68 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.70940086 |
| 69 | negative regulation of amino acid transport (GO:0051956) | 3.70232688 |
| 70 | intracellular lipid transport (GO:0032365) | 3.70039890 |
| 71 | negative regulation of gluconeogenesis (GO:0045721) | 3.66386436 |
| 72 | glycerol metabolic process (GO:0006071) | 3.64038055 |
| 73 | negative regulation of metanephros development (GO:0072217) | 3.63271139 |
| 74 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.62776709 |
| 75 | NADH metabolic process (GO:0006734) | 3.60803494 |
| 76 | cGMP-mediated signaling (GO:0019934) | 3.60553394 |
| 77 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.59469859 |
| 78 | negative regulation of granulocyte differentiation (GO:0030853) | 3.59233543 |
| 79 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.56715738 |
| 80 | 2-oxoglutarate metabolic process (GO:0006103) | 3.56538447 |
| 81 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.53398107 |
| 82 | tricarboxylic acid cycle (GO:0006099) | 3.51772019 |
| 83 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.51415689 |
| 84 | regulation of receptor binding (GO:1900120) | 3.49479227 |
| 85 | positive regulation of glycolytic process (GO:0045821) | 3.48364964 |
| 86 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.44808074 |
| 87 | growth hormone receptor signaling pathway (GO:0060396) | 3.40928376 |
| 88 | regulation of lipoprotein metabolic process (GO:0050746) | 3.39030146 |
| 89 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.38992961 |
| 90 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.38992961 |
| 91 | negative regulation of lipid storage (GO:0010888) | 3.37297387 |
| 92 | negative regulation of phagocytosis (GO:0050765) | 3.37188703 |
| 93 | positive regulation of cholesterol efflux (GO:0010875) | 3.36562851 |
| 94 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.35117530 |
| 95 | complement activation, alternative pathway (GO:0006957) | 3.34725053 |
| 96 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.32210150 |
| 97 | positive regulation of glomerulus development (GO:0090193) | 3.30835286 |
| 98 | monocarboxylic acid catabolic process (GO:0072329) | 3.30476036 |
| 99 | diacylglycerol metabolic process (GO:0046339) | 3.29151173 |
| 100 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.29112490 |
| 101 | positive regulation of sterol transport (GO:0032373) | 3.27847082 |
| 102 | positive regulation of cholesterol transport (GO:0032376) | 3.27847082 |
| 103 | quaternary ammonium group transport (GO:0015697) | 3.27560659 |
| 104 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.27418522 |
| 105 | long-chain fatty acid transport (GO:0015909) | 3.27134915 |
| 106 | cellular response to lithium ion (GO:0071285) | 3.24471316 |
| 107 | positive regulation of glucose transport (GO:0010828) | 3.21762589 |
| 108 | alditol metabolic process (GO:0019400) | 3.21377482 |
| 109 | regulation of triglyceride catabolic process (GO:0010896) | 3.20911364 |
| 110 | succinate metabolic process (GO:0006105) | 3.20789267 |
| 111 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.19500454 |
| 112 | glomerular filtration (GO:0003094) | 3.19226871 |
| 113 | primary alcohol metabolic process (GO:0034308) | 3.18615257 |
| 114 | phosphatidic acid biosynthetic process (GO:0006654) | 3.18530918 |
| 115 | phosphatidic acid metabolic process (GO:0046473) | 3.18530918 |
| 116 | pentose-phosphate shunt (GO:0006098) | 3.16193952 |
| 117 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.16003394 |
| 118 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.15225121 |
| 119 | coenzyme A metabolic process (GO:0015936) | 3.13079038 |
| 120 | L-serine transport (GO:0015825) | 3.11859512 |
| 121 | regulation of lipid storage (GO:0010883) | 3.11286451 |
| 122 | protein localization to cell surface (GO:0034394) | 3.10509954 |
| 123 | barbed-end actin filament capping (GO:0051016) | 3.10351288 |
| 124 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 3.10175038 |
| 125 | NADPH regeneration (GO:0006740) | 3.09126536 |
| 126 | negative regulation of macrophage differentiation (GO:0045650) | 3.08478112 |
| 127 | positive regulation of metanephros development (GO:0072216) | 3.07820203 |
| 128 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.06239199 |
| 129 | ethanol metabolic process (GO:0006067) | 3.06038091 |
| 130 | response to epinephrine (GO:0071871) | 3.04882288 |
| 131 | triglyceride homeostasis (GO:0070328) | 3.04521803 |
| 132 | acylglycerol homeostasis (GO:0055090) | 3.04521803 |
| 133 | phagocytosis, recognition (GO:0006910) | 3.02199639 |
| 134 | extracellular fibril organization (GO:0043206) | 3.01151160 |
| 135 | retinol metabolic process (GO:0042572) | 2.99947923 |
| 136 | cellular response to leptin stimulus (GO:0044320) | 2.99890038 |
| 137 | negative regulation of lipid catabolic process (GO:0050995) | 2.97112375 |
| 138 | response to vitamin E (GO:0033197) | 2.96723895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 6.25099057 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.45691146 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.89389930 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.67814749 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.59414946 |
| 6 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.39695308 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.30328942 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.29654822 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.22889535 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.13745597 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.13634097 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.11084803 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.06219346 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 13.9379151 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.97171473 |
| 16 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.90802210 |
| 17 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.86388233 |
| 18 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.77344196 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.76447338 |
| 20 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.74747095 |
| 21 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.74747095 |
| 22 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.70039568 |
| 23 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.65699204 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.62270993 |
| 25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.58551271 |
| 26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.56206181 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.43070947 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40847768 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.39145925 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31816533 |
| 31 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29628319 |
| 32 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28233726 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27142682 |
| 34 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.25647436 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22927182 |
| 36 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.22113481 |
| 37 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17817396 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17803290 |
| 39 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.15711122 |
| 40 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.14857874 |
| 41 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12802315 |
| 42 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.12415800 |
| 43 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.10092914 |
| 44 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.09840243 |
| 45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09158068 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07948656 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07119714 |
| 48 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.07015853 |
| 49 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.06882441 |
| 50 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.05007155 |
| 51 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.04548175 |
| 52 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04492203 |
| 53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04197772 |
| 54 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.04173612 |
| 55 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.04042221 |
| 56 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02580743 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02292669 |
| 58 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99476957 |
| 59 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99437026 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97214335 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95881313 |
| 62 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93955718 |
| 63 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.93105086 |
| 64 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92822310 |
| 65 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.92622823 |
| 66 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.90898659 |
| 67 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90755566 |
| 68 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.90308731 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87906062 |
| 70 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87135586 |
| 71 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.85586128 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84971135 |
| 73 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84586202 |
| 74 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84580845 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83727698 |
| 76 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83721799 |
| 77 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.83687891 |
| 78 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.82537860 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82513090 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82513090 |
| 81 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81824637 |
| 82 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81271148 |
| 83 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.80884840 |
| 84 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.80682954 |
| 85 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.80549646 |
| 86 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.79683578 |
| 87 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79338670 |
| 88 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.78842248 |
| 89 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.78799156 |
| 90 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.78599049 |
| 91 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.78599049 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78435899 |
| 93 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.78418784 |
| 94 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.78266601 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.78237239 |
| 96 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.78213059 |
| 97 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.76185764 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75512991 |
| 99 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75183074 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74625233 |
| 101 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73228031 |
| 102 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73016334 |
| 103 | KDM2B_26808549_Chip-Seq_K562_Human | 0.71955099 |
| 104 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71889410 |
| 105 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.71794489 |
| 106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.71475697 |
| 107 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.69919535 |
| 108 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.69816007 |
| 109 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.69735901 |
| 110 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.69066190 |
| 111 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.68917510 |
| 112 | CBP_21632823_ChIP-Seq_H3396_Human | 0.68809447 |
| 113 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.68707073 |
| 114 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.67837274 |
| 115 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.67790016 |
| 116 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.67605136 |
| 117 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.67206416 |
| 118 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.66859217 |
| 119 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.66479858 |
| 120 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.66197427 |
| 121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.66123761 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.65642760 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.65297059 |
| 124 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.64415978 |
| 125 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.63629685 |
| 126 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63547568 |
| 127 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63091615 |
| 128 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.61271738 |
| 129 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.61179273 |
| 130 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.61128491 |
| 131 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.60621127 |
| 132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60016019 |
| 133 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.59859594 |
| 134 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.59637788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 7.80175165 |
| 2 | MP0005666_abnormal_adipose_tissue | 5.24186982 |
| 3 | MP0004130_abnormal_muscle_cell | 4.89038340 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 4.41709718 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 4.33648023 |
| 6 | MP0004185_abnormal_adipocyte_glucose | 4.32651162 |
| 7 | MP0005375_adipose_tissue_phenotype | 3.95377707 |
| 8 | MP0000013_abnormal_adipose_tissue | 3.24793172 |
| 9 | MP0005275_abnormal_skin_tensile | 2.89120335 |
| 10 | MP0002971_abnormal_brown_adipose | 2.85058386 |
| 11 | MP0000003_abnormal_adipose_tissue | 2.77555376 |
| 12 | MP0002876_abnormal_thyroid_physiology | 2.70977693 |
| 13 | MP0009115_abnormal_fat_cell | 2.55702275 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.51096846 |
| 15 | MP0005334_abnormal_fat_pad | 2.29867250 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.27109482 |
| 17 | MP0000751_myopathy | 2.22030454 |
| 18 | MP0005503_abnormal_tendon_morphology | 2.11092142 |
| 19 | MP0003646_muscle_fatigue | 2.04769246 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.00529178 |
| 21 | MP0002970_abnormal_white_adipose | 1.92984411 |
| 22 | MP0001661_extended_life_span | 1.79108064 |
| 23 | MP0003868_abnormal_feces_composition | 1.78511856 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.78411109 |
| 25 | MP0004272_abnormal_basement_membrane | 1.70208742 |
| 26 | MP0003959_abnormal_lean_body | 1.69586295 |
| 27 | MP0003011_delayed_dark_adaptation | 1.66735019 |
| 28 | MP0005535_abnormal_body_temperature | 1.64437313 |
| 29 | MP0004215_abnormal_myocardial_fiber | 1.61610930 |
| 30 | MP0000750_abnormal_muscle_regeneration | 1.51533185 |
| 31 | MP0003690_abnormal_glial_cell | 1.48848243 |
| 32 | MP0004087_abnormal_muscle_fiber | 1.46736441 |
| 33 | MP0003828_pulmonary_edema | 1.45584423 |
| 34 | MP0006138_congestive_heart_failure | 1.45525525 |
| 35 | MP0005620_abnormal_muscle_contractility | 1.43617520 |
| 36 | MP0008775_abnormal_heart_ventricle | 1.39417124 |
| 37 | MP0000749_muscle_degeneration | 1.35596009 |
| 38 | MP0005448_abnormal_energy_balance | 1.32626537 |
| 39 | MP0000759_abnormal_skeletal_muscle | 1.29002929 |
| 40 | MP0005330_cardiomyopathy | 1.28465436 |
| 41 | MP0004036_abnormal_muscle_relaxation | 1.27528790 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.26951363 |
| 43 | MP0005452_abnormal_adipose_tissue | 1.25105602 |
| 44 | MP0004084_abnormal_cardiac_muscle | 1.24272532 |
| 45 | MP0001544_abnormal_cardiovascular_syste | 1.24204269 |
| 46 | MP0005385_cardiovascular_system_phenoty | 1.24204269 |
| 47 | MP0003186_abnormal_redox_activity | 1.21884153 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 1.16476284 |
| 49 | MP0003045_fibrosis | 1.16201835 |
| 50 | MP0005365_abnormal_bile_salt | 1.14013339 |
| 51 | MP0002972_abnormal_cardiac_muscle | 1.13615780 |
| 52 | MP0003724_increased_susceptibility_to | 1.12582315 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 1.11442143 |
| 54 | MP0000609_abnormal_liver_physiology | 1.10486423 |
| 55 | MP0003950_abnormal_plasma_membrane | 1.06638000 |
| 56 | MP0000343_altered_response_to | 1.05923701 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.05467900 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.04233536 |
| 59 | MP0003566_abnormal_cell_adhesion | 1.00092856 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 0.99845827 |
| 61 | MP0002933_joint_inflammation | 0.99636798 |
| 62 | MP0002060_abnormal_skin_morphology | 0.97260126 |
| 63 | MP0001501_abnormal_sleep_pattern | 0.96838437 |
| 64 | MP0000767_abnormal_smooth_muscle | 0.94848616 |
| 65 | MP0002106_abnormal_muscle_physiology | 0.94423975 |
| 66 | MP0002332_abnormal_exercise_endurance | 0.94238446 |
| 67 | MP0001727_abnormal_embryo_implantation | 0.94100941 |
| 68 | MP0002254_reproductive_system_inflammat | 0.93063060 |
| 69 | MP0005647_abnormal_sex_gland | 0.92797075 |
| 70 | MP0002108_abnormal_muscle_morphology | 0.88624048 |
| 71 | MP0004147_increased_porphyrin_level | 0.87750031 |
| 72 | MP0010630_abnormal_cardiac_muscle | 0.86556496 |
| 73 | MP0002269_muscular_atrophy | 0.86151786 |
| 74 | MP0005369_muscle_phenotype | 0.82614196 |
| 75 | MP0001881_abnormal_mammary_gland | 0.82076895 |
| 76 | MP0002796_impaired_skin_barrier | 0.81904527 |
| 77 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81341904 |
| 78 | MP0008961_abnormal_basal_metabolism | 0.74594165 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.73829711 |
| 80 | MP0000747_muscle_weakness | 0.73656556 |
| 81 | MP0003948_abnormal_gas_homeostasis | 0.73398154 |
| 82 | MP0000858_altered_metastatic_potential | 0.73119304 |
| 83 | MP0002006_tumorigenesis | 0.72583254 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72299860 |
| 85 | MP0005379_endocrine/exocrine_gland_phen | 0.71419163 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 0.71137087 |
| 87 | MP0004484_altered_response_of | 0.71080892 |
| 88 | MP0004145_abnormal_muscle_electrophysio | 0.71061888 |
| 89 | MP0001756_abnormal_urination | 0.70909970 |
| 90 | MP0002168_other_aberrant_phenotype | 0.69235371 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.68640372 |
| 92 | MP0002295_abnormal_pulmonary_circulatio | 0.67209059 |
| 93 | MP0001879_abnormal_lymphatic_vessel | 0.66086720 |
| 94 | MP0006276_abnormal_autonomic_nervous | 0.63768123 |
| 95 | MP0003953_abnormal_hormone_level | 0.63763546 |
| 96 | MP0001764_abnormal_homeostasis | 0.62898782 |
| 97 | MP0003279_aneurysm | 0.62615344 |
| 98 | MP0001958_emphysema | 0.62401619 |
| 99 | MP0004858_abnormal_nervous_system | 0.62356424 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.61626489 |
| 101 | MP0005266_abnormal_metabolism | 0.61131997 |
| 102 | MP0005164_abnormal_response_to | 0.60217935 |
| 103 | MP0003075_altered_response_to | 0.57219309 |
| 104 | MP0009643_abnormal_urine_homeostasis | 0.54713016 |
| 105 | MP0003091_abnormal_cell_migration | 0.53543863 |
| 106 | MP0005508_abnormal_skeleton_morphology | 0.53533025 |
| 107 | MP0002128_abnormal_blood_circulation | 0.53440959 |
| 108 | MP0005165_increased_susceptibility_to | 0.50961813 |
| 109 | MP0003879_abnormal_hair_cell | 0.50397175 |
| 110 | MP0005332_abnormal_amino_acid | 0.50045232 |
| 111 | MP0009672_abnormal_birth_weight | 0.49511722 |
| 112 | MP0000249_abnormal_blood_vessel | 0.49236049 |
| 113 | MP0005595_abnormal_vascular_smooth | 0.47260740 |
| 114 | MP0002133_abnormal_respiratory_system | 0.46280939 |
| 115 | MP0005388_respiratory_system_phenotype | 0.46280939 |
| 116 | MP0003137_abnormal_impulse_conducting | 0.46213103 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.45625677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 7.66792033 |
| 2 | Acanthosis nigricans (HP:0000956) | 6.37546053 |
| 3 | Hypertriglyceridemia (HP:0002155) | 5.40988975 |
| 4 | Difficulty running (HP:0009046) | 4.97918888 |
| 5 | Increased connective tissue (HP:0009025) | 4.90639603 |
| 6 | Myoglobinuria (HP:0002913) | 4.81559442 |
| 7 | Hyperglycinuria (HP:0003108) | 4.62630782 |
| 8 | Muscle fiber splitting (HP:0003555) | 4.48775587 |
| 9 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.22807165 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 3.90067898 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.76032993 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 3.76032993 |
| 13 | Rhabdomyolysis (HP:0003201) | 3.74820840 |
| 14 | Complement deficiency (HP:0004431) | 3.67575044 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 3.59756098 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.54422967 |
| 17 | Lipoatrophy (HP:0100578) | 3.52111261 |
| 18 | Increased variability in muscle fiber diameter (HP:0003557) | 3.44544548 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 3.27202688 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.19740107 |
| 21 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.19623486 |
| 22 | Broad metatarsal (HP:0001783) | 3.17731336 |
| 23 | Insulin resistance (HP:0000855) | 3.16995136 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 3.16848278 |
| 25 | Long foot (HP:0001833) | 3.14440831 |
| 26 | Back pain (HP:0003418) | 3.14393604 |
| 27 | Pigmentary retinal degeneration (HP:0001146) | 3.13969190 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.13687420 |
| 29 | Frequent falls (HP:0002359) | 3.13504877 |
| 30 | Ketoacidosis (HP:0001993) | 3.12701448 |
| 31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.06637545 |
| 32 | Hypercortisolism (HP:0001578) | 2.99095744 |
| 33 | Bone cyst (HP:0012062) | 2.95059838 |
| 34 | Facial diplegia (HP:0001349) | 2.92936281 |
| 35 | Abnormal eating behavior (HP:0100738) | 2.90473515 |
| 36 | Vertebral compression fractures (HP:0002953) | 2.89063168 |
| 37 | Hemorrhage of the eye (HP:0011885) | 2.88185049 |
| 38 | Ketosis (HP:0001946) | 2.87779778 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.87374238 |
| 40 | Ectopia lentis (HP:0001083) | 2.85821939 |
| 41 | Cerebral aneurysm (HP:0004944) | 2.85364764 |
| 42 | Polycythemia (HP:0001901) | 2.82005386 |
| 43 | Increased muscle lipid content (HP:0009058) | 2.79487162 |
| 44 | Axonal loss (HP:0003447) | 2.76270146 |
| 45 | Sudden death (HP:0001699) | 2.76194063 |
| 46 | Striae distensae (HP:0001065) | 2.74388037 |
| 47 | Myotonia (HP:0002486) | 2.74066626 |
| 48 | Subcapsular cataract (HP:0000523) | 2.73643483 |
| 49 | Spinal rigidity (HP:0003306) | 2.73258772 |
| 50 | Multiple enchondromatosis (HP:0005701) | 2.70601503 |
| 51 | Ankle contracture (HP:0006466) | 2.70236258 |
| 52 | Growth hormone excess (HP:0000845) | 2.69704984 |
| 53 | Proximal amyotrophy (HP:0007126) | 2.69109766 |
| 54 | Calf muscle hypertrophy (HP:0008981) | 2.64352392 |
| 55 | Hydroxyprolinuria (HP:0003080) | 2.63852523 |
| 56 | Abnormality of proline metabolism (HP:0010907) | 2.63852523 |
| 57 | Large hands (HP:0001176) | 2.60405950 |
| 58 | Abnormality of complement system (HP:0005339) | 2.55686830 |
| 59 | Muscle stiffness (HP:0003552) | 2.55629196 |
| 60 | Ventricular tachycardia (HP:0004756) | 2.52819387 |
| 61 | Hyperthyroidism (HP:0000836) | 2.52234447 |
| 62 | Epidermoid cyst (HP:0200040) | 2.50235834 |
| 63 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.47848634 |
| 64 | Hypercholesterolemia (HP:0003124) | 2.47692020 |
| 65 | Myocardial infarction (HP:0001658) | 2.47194439 |
| 66 | Shallow orbits (HP:0000586) | 2.46282564 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44494364 |
| 68 | Dicarboxylic aciduria (HP:0003215) | 2.44494364 |
| 69 | Testicular atrophy (HP:0000029) | 2.44377655 |
| 70 | Exercise-induced muscle cramps (HP:0003710) | 2.41548390 |
| 71 | Lymphangioma (HP:0100764) | 2.36545390 |
| 72 | Cervical subluxation (HP:0003308) | 2.36416661 |
| 73 | Gowers sign (HP:0003391) | 2.35670679 |
| 74 | Infantile muscular hypotonia (HP:0008947) | 2.35418154 |
| 75 | Skin nodule (HP:0200036) | 2.32986111 |
| 76 | Neck muscle weakness (HP:0000467) | 2.31825049 |
| 77 | Systemic lupus erythematosus (HP:0002725) | 2.31310162 |
| 78 | Easy fatigability (HP:0003388) | 2.27762221 |
| 79 | Hyperammonemia (HP:0001987) | 2.27567808 |
| 80 | Rimmed vacuoles (HP:0003805) | 2.26125930 |
| 81 | Prenatal maternal abnormality (HP:0002686) | 2.24966985 |
| 82 | Hyperglycemia (HP:0003074) | 2.24566916 |
| 83 | Colitis (HP:0002583) | 2.21757612 |
| 84 | Toxemia of pregnancy (HP:0100603) | 2.21332536 |
| 85 | Thyroid-stimulating hormone excess (HP:0002925) | 2.20552136 |
| 86 | Palpitations (HP:0001962) | 2.20512840 |
| 87 | Nausea (HP:0002018) | 2.20306259 |
| 88 | Hyperlipoproteinemia (HP:0010980) | 2.19506405 |
| 89 | Wormian bones (HP:0002645) | 2.18924516 |
| 90 | Mitral valve prolapse (HP:0001634) | 2.14190522 |
| 91 | Slender build (HP:0001533) | 2.13897314 |
| 92 | Hyperpituitarism (HP:0010514) | 2.13004544 |
| 93 | Hyperglycinemia (HP:0002154) | 2.12891948 |
| 94 | Abnormal cartilage morphology (HP:0002763) | 2.11618418 |
| 95 | Dilatation of the ascending aorta (HP:0005111) | 2.11156713 |
| 96 | Pulmonary artery stenosis (HP:0004415) | 2.10951686 |
| 97 | Ileus (HP:0002595) | 2.10924679 |
| 98 | Dilated cardiomyopathy (HP:0001644) | 2.10089709 |
| 99 | Atrioventricular block (HP:0001678) | 2.10029379 |
| 100 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.07827242 |
| 101 | Vascular tortuosity (HP:0004948) | 2.07242950 |
| 102 | Scapular winging (HP:0003691) | 2.07226277 |
| 103 | Premature rupture of membranes (HP:0001788) | 2.07210168 |
| 104 | Xanthomatosis (HP:0000991) | 2.05659529 |
| 105 | Foot dorsiflexor weakness (HP:0009027) | 2.05605210 |
| 106 | Accelerated skeletal maturation (HP:0005616) | 2.04111699 |
| 107 | Bulbar palsy (HP:0001283) | 1.99786692 |
| 108 | Abnormality of the calf musculature (HP:0001430) | 1.98862669 |
| 109 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.98547181 |
| 110 | Decreased subcutaneous fat (HP:0001002) | 1.98411329 |
| 111 | Hypoplasia of the iris (HP:0007676) | 1.93909067 |
| 112 | Atrial fibrillation (HP:0005110) | 1.93408367 |
| 113 | Follicular hyperkeratosis (HP:0007502) | 1.93349082 |
| 114 | Esophageal varix (HP:0002040) | 1.92689055 |
| 115 | Joint hemorrhage (HP:0005261) | 1.92560948 |
| 116 | Muscle fiber inclusion bodies (HP:0100299) | 1.92243457 |
| 117 | Abnormal hemoglobin (HP:0011902) | 1.91854931 |
| 118 | Asymmetric septal hypertrophy (HP:0001670) | 1.91558549 |
| 119 | Venous abnormality (HP:0002624) | 1.91456688 |
| 120 | Pancreatitis (HP:0001733) | 1.91149611 |
| 121 | Abnormality of the foot musculature (HP:0001436) | 1.90774516 |
| 122 | Aortic aneurysm (HP:0004942) | 1.88332181 |
| 123 | Enlarged penis (HP:0000040) | 1.88059018 |
| 124 | Tetraparesis (HP:0002273) | 1.86769609 |
| 125 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.86118762 |
| 126 | Prominent supraorbital ridges (HP:0000336) | 1.86112079 |
| 127 | Rectal prolapse (HP:0002035) | 1.85266229 |
| 128 | Distal lower limb amyotrophy (HP:0008944) | 1.83517468 |
| 129 | Soft skin (HP:0000977) | 1.83512659 |
| 130 | Increased serum pyruvate (HP:0003542) | 1.83028097 |
| 131 | Conjunctival hamartoma (HP:0100780) | 1.82645697 |
| 132 | Aneurysm (HP:0002617) | 1.82573917 |
| 133 | Obstructive sleep apnea (HP:0002870) | 1.81545886 |
| 134 | Aortic dissection (HP:0002647) | 1.80935107 |
| 135 | Abnormal atrioventricular conduction (HP:0005150) | 1.80443347 |
| 136 | Polyphagia (HP:0002591) | 1.80423886 |
| 137 | Stridor (HP:0010307) | 1.78621443 |
| 138 | Nemaline bodies (HP:0003798) | 1.78550436 |
| 139 | EMG: myopathic abnormalities (HP:0003458) | 1.78272170 |
| 140 | Protrusio acetabuli (HP:0003179) | 1.78110232 |
| 141 | Amyloidosis (HP:0011034) | 1.77845541 |
| 142 | Polar cataract (HP:0010696) | 1.77349312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 5.80992586 |
| 2 | TRIB3 | 5.41938207 |
| 3 | CAMK1G | 4.30195576 |
| 4 | SIK1 | 4.02976666 |
| 5 | BCKDK | 3.74900337 |
| 6 | LMTK2 | 3.09832348 |
| 7 | PDK3 | 2.93125886 |
| 8 | PDK4 | 2.93125886 |
| 9 | TTN | 2.73354838 |
| 10 | RIPK1 | 2.58412249 |
| 11 | PHKG2 | 2.13678459 |
| 12 | PHKG1 | 2.13678459 |
| 13 | TESK1 | 2.10774104 |
| 14 | MST1R | 2.05938534 |
| 15 | OBSCN | 2.00614544 |
| 16 | INSRR | 1.92251880 |
| 17 | PRKAA2 | 1.86832218 |
| 18 | MAPK4 | 1.75424950 |
| 19 | PDK2 | 1.74346387 |
| 20 | PIK3CA | 1.61349227 |
| 21 | ERN1 | 1.54463855 |
| 22 | FGFR2 | 1.51459043 |
| 23 | PDGFRA | 1.45018711 |
| 24 | FGFR3 | 1.45008504 |
| 25 | MYLK | 1.36898150 |
| 26 | EPHA3 | 1.34829956 |
| 27 | MAP3K13 | 1.34225747 |
| 28 | FRK | 1.28457162 |
| 29 | TIE1 | 1.26079908 |
| 30 | GRK5 | 1.17043142 |
| 31 | PRKD3 | 1.16662390 |
| 32 | RIPK4 | 1.14112751 |
| 33 | PKN2 | 1.11595950 |
| 34 | MOS | 1.09955904 |
| 35 | CDK9 | 1.05959322 |
| 36 | PRKAA1 | 1.05795913 |
| 37 | LATS1 | 1.02000687 |
| 38 | DDR2 | 1.01033735 |
| 39 | JAK1 | 0.98483686 |
| 40 | TGFBR2 | 0.98366052 |
| 41 | PINK1 | 0.98015471 |
| 42 | NLK | 0.96957204 |
| 43 | KIT | 0.96649627 |
| 44 | EPHB2 | 0.95271473 |
| 45 | MAP3K6 | 0.94875278 |
| 46 | ARAF | 0.94045782 |
| 47 | MAPK7 | 0.92542856 |
| 48 | DMPK | 0.91927523 |
| 49 | PRPF4B | 0.91828553 |
| 50 | CDK6 | 0.87746551 |
| 51 | MET | 0.86531188 |
| 52 | MAP2K1 | 0.83459891 |
| 53 | PRKCH | 0.81964359 |
| 54 | FGFR4 | 0.81789217 |
| 55 | PDPK1 | 0.80846324 |
| 56 | KDR | 0.80778064 |
| 57 | NEK9 | 0.80243429 |
| 58 | TYK2 | 0.78810570 |
| 59 | FER | 0.76971461 |
| 60 | CDC42BPA | 0.75572245 |
| 61 | FES | 0.74785942 |
| 62 | ILK | 0.74294065 |
| 63 | PRKD1 | 0.73942504 |
| 64 | PRKG1 | 0.72316793 |
| 65 | MTOR | 0.70121706 |
| 66 | MAP2K3 | 0.69065592 |
| 67 | PTK2 | 0.67918606 |
| 68 | ADRBK1 | 0.67424024 |
| 69 | JAK2 | 0.65274920 |
| 70 | STK38L | 0.65090744 |
| 71 | PTK2B | 0.62618596 |
| 72 | PRKACG | 0.61797105 |
| 73 | MAPK12 | 0.61413906 |
| 74 | PDK1 | 0.61197798 |
| 75 | PDGFRB | 0.60990703 |
| 76 | CAMK1 | 0.59488731 |
| 77 | RET | 0.58438587 |
| 78 | PKN1 | 0.57935430 |
| 79 | KSR2 | 0.57855775 |
| 80 | MAPK3 | 0.55907134 |
| 81 | MARK1 | 0.53264715 |
| 82 | LATS2 | 0.52714197 |
| 83 | MAPK11 | 0.52439028 |
| 84 | PRKACB | 0.51206832 |
| 85 | TBK1 | 0.50376589 |
| 86 | IRAK3 | 0.48968392 |
| 87 | IGF1R | 0.48892913 |
| 88 | PIK3CG | 0.48208280 |
| 89 | MAPKAPK3 | 0.48087078 |
| 90 | GSK3A | 0.46813952 |
| 91 | CAMKK2 | 0.46642186 |
| 92 | MAP3K1 | 0.45977980 |
| 93 | MAP3K7 | 0.45716500 |
| 94 | ZAP70 | 0.45666014 |
| 95 | EEF2K | 0.45032592 |
| 96 | HIPK2 | 0.43192201 |
| 97 | PAK2 | 0.42640570 |
| 98 | MARK2 | 0.42086385 |
| 99 | CSK | 0.41344467 |
| 100 | PAK4 | 0.41148820 |
| 101 | TRPM7 | 0.40757270 |
| 102 | FGFR1 | 0.40578950 |
| 103 | EPHB1 | 0.38028081 |
| 104 | MAP2K4 | 0.36678912 |
| 105 | BLK | 0.36106702 |
| 106 | ABL1 | 0.35966832 |
| 107 | PRKD2 | 0.35965273 |
| 108 | ICK | 0.35682918 |
| 109 | INSR | 0.35341006 |
| 110 | SGK2 | 0.34183534 |
| 111 | RPS6KA2 | 0.34075018 |
| 112 | FLT3 | 0.34031687 |
| 113 | MAP3K3 | 0.33596849 |
| 114 | CDK4 | 0.32794500 |
| 115 | MAPK1 | 0.32189421 |
| 116 | DAPK2 | 0.31758546 |
| 117 | ROCK1 | 0.30776014 |
| 118 | STK11 | 0.30638408 |
| 119 | PRKG2 | 0.29858831 |
| 120 | BMX | 0.29811299 |
| 121 | CSF1R | 0.28890086 |
| 122 | PTK6 | 0.28866983 |
| 123 | SRC | 0.28787825 |
| 124 | EIF2AK2 | 0.27275404 |
| 125 | SGK3 | 0.24510602 |
| 126 | JAK3 | 0.24454417 |
| 127 | RPS6KB1 | 0.23849035 |
| 128 | PAK3 | 0.22777457 |
| 129 | STK38 | 0.21507147 |
| 130 | RPS6KA3 | 0.21315693 |
| 131 | ABL2 | 0.21161805 |
| 132 | PRKACA | 0.19727445 |
| 133 | LRRK2 | 0.19591312 |
| 134 | NEK1 | 0.15887125 |
| 135 | AKT2 | 0.15852535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.52608839 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.36309154 |
| 3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.25703253 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.25410470 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.91984832 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.34743314 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.33967104 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.97105885 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.92568588 |
| 10 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.72980124 |
| 11 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.31174818 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.23073937 |
| 13 | AMPK signaling pathway_Homo sapiens_hsa04152 | 2.09600875 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95826919 |
| 15 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85334450 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.85114239 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72117961 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.67756738 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61349473 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.55296086 |
| 21 | Insulin resistance_Homo sapiens_hsa04931 | 1.48587832 |
| 22 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.42092469 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.41246312 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.32933066 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28537902 |
| 26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26723393 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.19915433 |
| 28 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.15125541 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.10489445 |
| 30 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.08846431 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07262114 |
| 32 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.98896211 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.98352240 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97578496 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96119250 |
| 36 | Malaria_Homo sapiens_hsa05144 | 0.95873166 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 0.94365078 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88555710 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86462512 |
| 40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83443209 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82284339 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77360413 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74442289 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.72585973 |
| 45 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72117675 |
| 46 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71941194 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71368255 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.70641844 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 0.70098894 |
| 50 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68036333 |
| 51 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66276795 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.66276439 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64078791 |
| 54 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63211433 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62789762 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61924321 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60339807 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59423336 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58710498 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53157537 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52247486 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.51630205 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50835822 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49416446 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47658200 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47356708 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46286297 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44569729 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44414682 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44034078 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43714166 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43129666 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43067717 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42697248 |
| 75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.39978040 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39652977 |
| 77 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.37633861 |
| 78 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37486311 |
| 79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.36453224 |
| 80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.34297663 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.32669380 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.32239789 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.31264055 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.29832732 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28820268 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.26538937 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24967911 |
| 88 | Melanogenesis_Homo sapiens_hsa04916 | 0.24235997 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23928802 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.23908090 |
| 91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.22671715 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.22599568 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.21925483 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.21246653 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.20635011 |
| 96 | Morphine addiction_Homo sapiens_hsa05032 | 0.20214804 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19376169 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19101482 |
| 99 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.18943642 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.18906248 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.18627974 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.17801163 |
| 103 | Salivary secretion_Homo sapiens_hsa04970 | 0.17599790 |
| 104 | Gap junction_Homo sapiens_hsa04540 | 0.16991338 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.16982761 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.15904735 |
| 107 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.15540310 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14934859 |
| 109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.14714243 |
| 110 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.13694148 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.12940897 |
| 112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.12771080 |
| 113 | Other glycan degradation_Homo sapiens_hsa00511 | 0.12732776 |
| 114 | Tight junction_Homo sapiens_hsa04530 | 0.12666011 |
| 115 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.12061515 |
| 116 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.11877828 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.11663089 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11212628 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.11022850 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.10905094 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.09349474 |
| 122 | Bile secretion_Homo sapiens_hsa04976 | 0.09214372 |
| 123 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.09059407 |
| 124 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.09040212 |
| 125 | Parkinsons disease_Homo sapiens_hsa05012 | 0.08855952 |
| 126 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.07507184 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.07466287 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.07449150 |
| 129 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.06947359 |

